Institutional investors purchased a net $5.4 million shares of NVO during the quarter ended September 2016, and now own 9.25% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOOMIS, SAYLES & CO. LP Bought 3.3 Million shares of Novo Nordisk
SUSTAINABLE GROWTH ADVISERS LP Bought 1.9 Million shares of Novo Nordisk
RENAISSANCE TECHNOLOGIES LLC Bought 1.7 Million shares of Novo Nordisk